Literatuurlijst

         1. Weijerman ME, de Winter JP. Clinical practice : The care of children with Down syndrome. Eur J Pediatr. 2010.

         2.     Mohangoo AD, Buitendijk SE. TNO report on Congenital defects in the Netherlands 1997-2007. Leiden: Netherlands Organisation for Applied Scientific Research TNO division Quality of Life; 2009.

         3.     Anthony S, Dorrepaal CA, Kateman H, Pal van der-Bruin KM. TNO report on Congenital defects in the Netherlands 1996-2003. Leiden: Netherlands Organisation for Applied Scientific Research TNO division Quality of Life; 2005.

         4.     Graaf de G. Een historisch demografisch model voor Downsyndroom plus een aantal toepassingen. Down+Up. 2007;76:37-48.

         5.     Weijerman ME, van Furth AM, Vonk NA, van Wouwe JP, Broers CJ, Gemke RJ. Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study. J Pediatr. 2008;152:15-19.

         6.     Vegelin M, Mostart P, Winkler L, Weijerman M. Downsyndroom, alle medische problemen op een rij. Artsen voor Kinderen; 2010.

         7.     Skotko BG. Prenatally diagnosed Down syndrome: mothers who continued their pregnancies evaluate their health care providers. Am J Obstet Gynecol. 2005;192:670-677.

         8.     Williams C, Alderson P, Farsides B. What constitutes 'balanced' information in the practitioners' portrayals of Down's syndrome? Midwifery. 2002;18:230-237.

         9.     Skotko BG, Kishnani PS, Capone GT. Prenatal diagnosis of Down syndrome: how best to deliver the news. Am J Med Genet A. 2009;149A:2361-2367.

      10.     Helm DT, Miranda S, Chedd NA. Prenatal diagnosis of Down syndrome: mothers' reflections on supports needed from diagnosis to birth. Ment Retard. 1998;36:55-61.

      11.     Korenromp MJ, Page-Christiaens GC, van den BJ, Mulder EJ, Visser GH. Maternal decision to terminate pregnancy in case of Down syndrome. Am J Obstet Gynecol. 2007;196:149-11.

      12.     Pueschel s. Phenotypic characteristics. In: Pueschel SM, Pueschel JK, editors. Biomedical concerns in persons with Down syndrome.Baltimore: Brooks; 1992.

      13.     Kava MP, Tullu MS, Muranjan MN, Girisha KM. Down syndrome: clinical profile from India. Arch Med Res. 2004;35:31-35.

      14.     Azman BZ, Ankathil R, Siti M, I, Suhaida MA, Norhashimah M, Tarmizi AB, et al. Cytogenetic and clinical profile of Down syndrome in Northeast Malaysia. Singapore Med J. 2007;48:550-554.

      15.     Christianson AL. Down syndrome in black South African infants and children--clinical features and delayed diagnosis. S Afr Med J. 1997;87:992-995.

      16.     Pavarino Bertelli EC, Biselli JM, Bonfim D, Goloni-Bertollo EM. Clinical profile of children with Down syndrome treated in a genetics outpatient service in the southeast of Brazil. Rev Assoc Med Bras. 2009;55:547-552.

      17.     Christianson AL, Kromberg JG, Viljoen E. Clinical features of Black African neonates with Down's syndrome. East Afr Med J. 1995;72:306-310.

      18.     Hall B. Mongolism in newborns: a clinical and cytogentic study. Acta Paediatr Suppl. 1964;154:SUPPL-95.

      19.     Fried K. A score based on eight signs in the diagnosis of Down syndrome in the newborn. J Ment Defic Res. 1980;24:181-185.

      20.     Jackson JF, North ER, III, Thomas JG. Clinical diagnosis of Down's syndrome. Clin Genet. 1976;9:483-487.

      21.     Geraedts J, Cassiman J. Chromosomale overerving. In: Pronk JC, et al, editors. Leerboek medische genetica. 6e ed. Elsevier/Bunge; 1999. 114-116.

      22.     McKinlay Gardner R, Sutherland G. Chromosome Abnormalities and genetic counseling. Oxford: 2004.

      23.     Weijerman ME, Wouwe van JP. Het (vermoeden) van Downsyndroom. In: Rodrigues Perreira R, editor. Jaarverslag NSCK.Leiden: TNO Kwaliteit van Leven; 2004.

      24.     Modi D, Berde P, Bhartiya D. Down syndrome: a study of chromosomal mosaicism. Reprod Biomed Online. 2003;6:499-503.

      25.     Devlin L, Morrison PJ. Accuracy of the clinical diagnosis of Down syndrome. Ulster Med J. 2004;73:4-12.

      26.     Hindley D, Medakkar S. Diagnosis of Down's syndrome in neonates. Arch Dis Child Fetal Neonatal Ed. 2002;87:F220-F221.

      27.     Skotko BG, Kishnani PS, Capone GT. Prenatal diagnosis of Down syndrome: how best to deliver the news. Am J Med Genet A. 2009;149A:2361-2367.

      28.     Cunningham CC, Morgan PA, McGucken RB. Down's syndrome: is dissatisfaction with disclosure of diagnosis inevitable? Dev Med Child Neurol. 1984;26:33-39.

      29.     Skotko B. Mothers of children with Down syndrome reflect on their postnatal support. Pediatrics. 2005;115:64-77.

      30.     Taanila A, Kokkonen J, Jarvelin MR. The long-term effects of children's early-onset disability on marital relationships. Dev Med Child Neurol. 1996;38:567-577.

      31.     Taanila A, Jarvelin MR, Kokkonen J. Parental guidance and counselling by doctors and nursing staff: parents' views of initial information and advice for families with disabled children. J Clin Nurs. 1998;7:505-511.

      32.     Muggli EE, Collins VR, Marraffa C. Going down a different road: first support and information needs of families with a baby with Down syndrome. Med J Aust. 2009;190:58-61.

      33.     Cunningham C. Families of children with Down Syndrome. Down Syndrome Res Pract. 1996;4:87-95.

      34.     Cunningham C. Intelligence development and attainments. Down Syndrome. An introduction for parents and carers. 3 ed. London: Souvenir Press; 2006.

      35.     Sacks B, Buckley S. Motor development for individuals with Down syndrome - An overview. Down Syndrome Issues and Information. 2003.

      36.     Rynders J, Abery B, Spiker D. Improving educational programming for individuals with Down syndrome: engaging the fuller competence. Down Syndrome Quarterly. 1997;2:1-11.

      37.     Rynders JE. Supporting the educational development and progress of persons with Down syndrome. Caring for individuals with Down syndrome and their families. Report of the third Ross roundtable on critical issues in family medicine in collaboration with the society of teachers of family medicine.Columbus (Ohio): Ross Products Division, Abott Laboratories; 1995.

      38.     Wishart JG. Cognitive development in young children with Down syndrome: Developmental strengths, developmental weaknesses. In: Virji-Babul N, Kisly D, editors. Down syndrome in the 21st centery: 1st biennial scientific conference on Down syndrome.Canada: 1998.

      39.     Hodapp RM. Cognitive functioning: issues in theory and practice. In: Pueschel SM, Sustrova M, editors. Adolescents with Down syndrome: towards a more fulfilling life.Baltimore/London: Paul H. Brookes Publishing Co.; 1997.

      40.     Shonkoff JF, Meisels JM. Handbook of early childhood intervention. 2e editie ed. New York: Cambridge University Press; 2000.

      41.     Kleine Stapjes, Early Intervention-prograam, supplement Schoolse Vaardigheden en instructievideo. Bussum: V& V Producties; 2010.

      42.     Galli M, Rigoldi C, Mainardi L, Tenore N, Onorati P, Albertini G. Postural control in patients with Down syndrome. Disabil Rehabil. 2008;30:1274-1278.

      43.     Fidler DJ. The emerging Down syndrome behavioral phenotype in early childhood: implications for practice. Infants Young Children. 2005;18:86-103.

      44.     Lauteslager PEM. Kinderen met het syndroom van Down: Motorische ontwikkeling en behandeling. Proefschrift. Amersfoort: 's Heeren Loo Zorggroep; 2000.

      45.     Volman MJ, Visser JJ, Lensvelt-Mulders GJ. Functional status in 5 to 7-year-old children with Down syndrome in relation to motor ability and performance mental ability. Disabil Rehabil. 2007;29:25-31.

      46.     Lauteslager P, Heuvel van den M, Bakker B. Fysiotherapie voor jonge kinderen met Downsyndroom. Signaal. 2008;63:4-26.

      47.     Heuvel van den ME, de J, I, Lauteslager PE, Volman MJ. Responsiveness of the Test of Basic Motor Skills of Children with Down Syndrome. Phys Occup Ther Pediatr. 2009;29:71-85.

      48.     Lauteslager P, Vermeer A, Helders P. Het effect van fysiotherapie op de ontwikkeling van basismotorische vaardigheden van kinderen met het syndroom van Down. Ned Tijdsch Fysiotherapie. 2000;110:12-21.

      49.     Russell D, Palisano R, Walter S, Rosenbaum P, Gemus M, Gowland C, et al. Evaluating motor function in children with Down syndrome: validity of the GMFM. Dev Med Child Neurol. 1998;40:693-701.

      50.     Palisano RJ, Walter SD, Russell DJ, Rosenbaum PL, Gemus M, Galuppi BE, et al. Gross motor function of children with down syndrome: creation of motor growth curves. Arch Phys Med Rehabil. 2001;82:494-500.

      51.     Ulrich DA, Ulrich BD, ngulo-Kinzler RM, Yun J. Treadmill training of infants with Down syndrome: evidence-based developmental outcomes. Pediatrics. 2001;108:E84.

      52.     Angulo-Barroso RM, Wu J, Ulrich DA. Long-term effect of different treadmill interventions on gait development in new walkers with Down syndrome. Gait Posture. 2008;27:231-238.

      53.     Wu J, Ulrich DA, Looper J, Tiernan CW, ngulo-Barroso RM. Strategy adoption and locomotor adjustment in obstacle clearance of newly walking toddlers with Down syndrome after different treadmill interventions. Exp Brain Res. 2008;186:261-272.

      54.     Mahoney G, Robinson C, Fewell RR. The effects of early motor intervention on children with Down syndrome or cerebral palsy: a field-based study. J Dev Behav Pediatr. 2001;22:153-162.

      55.     Mahoney G, Perales F. The role of parents in early motor intervention. Downs Syndr Res Pract. 2006;10:67-73.

      56.     http://www.ds-health.com/occther.htm geraadpleegd augustus. 2010.

      57.     Werkgroep VBVC. Richtlijnen voor de logopedische behandeling van jonge kinderen met het syndroom van Down. Assen: 2009.

      58.     Van den Engel-Hoek L. Downsyndroom en slikken. Problemen in de orale, faryngeale en oesofageale fase van het slikken. Tijdschrift voor Logopedie en Foniatrie. 2005;77:374-379.

      59.     Hennequin M, Allison PJ, Veyrune JL. Prevalence of oral health problems in a group of individuals with Down syndrome in France. Dev Med Child Neurol. 2000;42:691-698.

      60.     Thompson RH, Cotnoir-Bichelman NM, McKerchar PM, Tate TL, Dancho KA. Enhancing early communication through infant sign training. J Appl Behav Anal. 2007;40:15-23.

      61.     Zarate N, Mearin F, Gil-Vernet JM, Camarasa F, Malagelada JR. Achalasia and Down's syndrome: coincidental association or something else? Am J Gastroenterol. 1999;94:1674-1677.

      62.     Van Akkeren W. Sensorische integratie principes en Downsyndroom. Persoonlijke ervaringen uit de praktijk. Tijdschrift voor Logopedie en Foniatrie. 2005;77:388-394.

      63.     Mitchell RB, Call E, Kelly J. Ear, nose and throat disorders in children with Down syndrome. Laryngoscope. 2003;113:259-263.

      64.     De Graaf E. Kinderen met Downsyndroom. Hoe krijgen we ze aan de praat? Tijdschrift voor Logopedie en Foniatrie. 2005;368-372.

      65.     Moura CP, Cunha LM, Vilarinho H, Cunha MJ, Freitas D, Palha M, et al. Voice parameters in children with Down syndrome. J Voice. 2008;22:34-42.

      66.     Nederlands gebarencentrum. http://www.gebarencentrum.nl/uitleg_nmg.asp. Geraadpleegd augustus 2010. 2010.

      67.     Buma J. Leren lezen om te leren spreken. Stimulatie van spraak- en taalontwikkeling bij kinderen met Downsyndroom. Tijdschrift voor Logopedie en Foniatrie. 2005;77:396-400.

      68.     Down Syndrome Education International. www.downsed.org. Geraadpleegd augustus 2010. 2010.

      69.     Miller J. De ontwikkeling van taalvaardigheden bij kinderen met Down's syndroom. Down+Up. 1994;25:9-12.

      70.     Brock J, Jarrold C. Serial order reconstruction in Down syndrome: evidence for a selective deficit in verbal short-term memory. J Child Psychol Psychiatry. 2005;46:304-316.

      71.     Buckley S. Het bevorderen van de cognitieve ontwikkeling; praktische implicaties van recent onderzoek bij kinderen met Downsyndroom. Down=Up. 1998;44:1-6.

      72.     Rondal J. Werkgeheugen bij Down's syndroom. Down+Up. 1994;28:6-8.

      73.     Baksi L. What can we do about dysfluency, stammering, getting stuck? DSA Journal. 2005;108:15-21.

      74.     te Kaat-vanden Os D. Samen leren communiceren. Het effect van gebaren op de woordontwikkeling bij kinderen met Downsyndroom. Logopedie en Foniatrie. 2007;7/8.

      75.     Buckley S, Bird G, Sacks B. Social development for individuals with Down syndrome - An overview. Down Syndrome Issues and Information. 2002.

      76.     Dolva AS, Coster W, Lilja M. Functional performance in children with Down syndrome. Am J Occup Ther. 2004;58:621-629.

      77.     Hicks JA, Carson C, Malone PS. Is there an association between functional bladder outlet obstruction and Down's syndrome? J Pediatr Urol. 2007;3:369-374.

      78.     Luske T. Zindelijkheidsproblemen bij kinderen van zeven tot en met achttien jaar met het syndroom van Down. Stageverslag masterfase, begeleider ME Weijerman, VUmc. 2009.

      79.     Torfs CP, Christianson RE. Anomalies in Down syndrome individuals in a large population-based registry. Am J Med Genet. 1998;77:431-438.

      80.     Mercer ES, Broecker B, Smith EA, Kirsch AJ, Scherz HC, Massad A. Urological manifestations of Down syndrome. J Urol. 2004;171:1250-1253.

      81.     Kupferman JC, Druschel CM, Kupchik GS. Increased prevalence of renal and urinary tract anomalies in children with Down syndrome. Pediatrics. 2009;124:e615-e621.

      82.     Ebert AK, Brookman-Amissah S, Rosch WH. [Urological manifestations of Down syndrome: significance and long-term complications -- our own patient cohort with an overview]. Urologe A. 2008;47:337-341.

      83.     Handel LN, Barqawi A, Checa G, Furness PD, III, Koyle MA. Males with Down's syndrome and nonneurogenic neurogenic bladder. J Urol. 2003;169:646-649.

      84.     Capone G, Goyal P, Ares W, Lannigan E. Neurobehavioral disorders in children, adolescents, and young adults with Down syndrome. Am J Med Genet C Semin Med Genet. 2006;142C:158-172.

      85.     Dykens EM. Psychiatric and behavioral disorders in persons with Down syndrome. Ment Retard Dev Disabil Res Rev. 2007;13:272-278.

      86.     Myers B, Pueschel SM. Tardive or atypical Tourette's disorder in a population with Down syndrome? Res Dev Disabil. 1995;16:1-9.

      87.     Capone GT, Grados MA, Kaufmann WE, Bernad-Ripoll S, Jewell A. Down syndrome and comorbid autism-spectrum disorder: characterization using the aberrant behavior checklist. Am J Med Genet A. 2005;134:373-380.

      88.     Capone GT, Goyal P, Grados M, Smith B, Kammann H. Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: a naturalistic study. J Dev Behav Pediatr. 2008;29:106-116.

      89.     Carter JC, Capone GT, Gray RM, Cox CS, Kaufmann WE. Autistic-spectrum disorders in Down syndrome: further delineation and distinction from other behavioral abnormalities. Am J Med Genet B Neuropsychiatr Genet. 2007;144B:87-94.

      90.     Castillo H, Patterson B, Hickey F, Kinsman A, Howard JM, Mitchell T, et al. Difference in age at regression in children with autism with and without Down syndrome. J Dev Behav Pediatr. 2008;29:89-93.

      91.     Kent L, Evans J, Paul M, Sharp M. Comorbidity of autistic spectrum disorders in children with Down syndrome. Dev Med Child Neurol. 1999;41:153-158.

      92.     Evans DW, Gray FL. Compulsive-like behavior in individuals with Down syndrome: its relation to mental age level, adaptive and maladaptive behavior. Child Dev. 2000;71:288-300.

      93.     Lowenthal R, Paula CS, Schwartzman JS, Brunoni D, Mercadante MT. Prevalence of pervasive developmental disorder in Down's syndrome. J Autism Dev Disord. 2007;37:1394-1395.

      94.     Hastings RP, Beck A, Daley D, Hill C. Symptoms of ADHD and their correlates in children with intellectual disabilities. Res Dev Disabil. 2005;26:456-468.

      95.     Maatta T, Tervo-Maatta T, Taanila A, Kaski M, Iivanainen M. Mental health, behaviour and intellectual abilities of people with Down syndrome. Downs Syndr Res Pract. 2006;11:37-43.

      96.     Kerbeshian J, Burd L. Comorbid Down's syndrome, Tourette syndrome and intellectual disability: registry prevalence and developmental course. J Intellect Disabil Res. 2000;44 ( Pt 1):60-67.

      97.     Mantry D, Cooper SA, Smiley E, Morrison J, Allan L, Williamson A, et al. The prevalence and incidence of mental ill-health in adults with Down syndrome. J Intellect Disabil Res. 2008;52:141-155.

      98.     Wet op de Jeugdzorg. 2004.

      99.     IJzendoorn van M, Prinzle P, Euser E, Groenveld M, Brilleslijper-Kater S, van Noort-van der Linden A, et al. Kindermishandeling in Nederland anno 2005: De nationale prevalentiestudie mishandeling van kinderen en jeugdigen (NPM-2005). Leiden: Rijksuniversiteit Leiden; 2007.

   100.     Postma S. JGZ-richtlijn Vroegsignalering van psychosociale problemen. Bilthoven: RIVM/Centrum Jeugdgezondheid; 2008.

   101.     Wishart JG. Socio-cognitive understanding: a strength or weakness in Down's syndrome? J Intellect Disabil Res. 2007;51:996-1005.

   102.     Kaptein S. Mental health problems in children with intellectual disability: use of the Strengths and difficulties Questionnaire. Journal of Intellectual Disability Research. 2007;53:125-131.

   103.     Artsen en kindermishandeling. Meldcode en stappenplan. Utrecht: KNMG; 2008.

   104.     NJI site http://www.nji.nl/eCache/DEF/1/06/194.html Geraadpleegd augustus. 2010.

   105.     Lijst van Downteams/poli's in Nederland; http://www.downsyndroom.nl/cms/publish/content/showpage.asp?pageid=296; Geraadpleegd augustus 2010. 2010.

   106.     Cooley WC, McAllister JW, Sherrieb K, Kuhlthau K. Improved outcomes associated with medical home implementation in pediatric primary care. Pediatrics. 2009;124:358-364.

   107.     Palfrey JS, Sofis LA, Davidson EJ, Liu J, Freeman L, Ganz ML. The Pediatric Alliance for Coordinated Care: evaluation of a medical home model. Pediatrics. 2004;113:1507-1516.

   108.     Bodenheimer T. Coordinating care--a perilous journey through the health care system. N Engl J Med. 2008;358:1064-1071.

   109.     Richtlijnen CBO; www.cbo.nl. 2010.

   110.     Freeman SB, Torfs CP, Romitti PA, Royle MH, Druschel C, Hobbs CA, et al. Congenital gastrointestinal defects in Down syndrome: a report from the Atlanta and National Down Syndrome Projects. Clin Genet. 2009;75:180-184.

   111.     Roofthooft MT, van MH, Rietman WG, Ebels T, Berger RM. Down syndrome and aberrant right subclavian artery. Eur J Pediatr. 2008;167:1033-1036.

   112.     Roizen NJ, Patterson D. Down's syndrome. Lancet. 2003;361:1281-1289.

   113.     Pisacane A, Toscano E, Pirri I, Continisio P, Andria G, Zoli B, et al. Down syndrome and breastfeeding. Acta Paediatr. 2003;92:1479-1481.

   114.     Aumonier ME, Cunningham CC. Breast feeding in infants with Down's syndrome. Child Care Health Dev. 1983;9:247-255.

   115.     Fitzsimons R. Developmental, psychosocial, and educational factors in children with nonorganic articulation problems. Child Dev. 1958;29:483-489.

   116.     Hopman E, Csizmadia CG, Bastiani WF, Engels QM, de Graaf EA, le CS, et al. Eating habits of young children with Down syndrome in The Netherlands: adequate nutrient intakes but delayed introduction of solid food. J Am Diet Assoc. 1998;98:790-794.

   117.     Taylor B, Wadsworth J. Breast feeding and child development at five years. Dev Med Child Neurol. 1984;26:73-80.

   118.     Sanchez-Albisua I, Storm W, Wascher I, Stern M. How frequent is coeliac disease in Down syndrome? Eur J Pediatr. 2002;161:683-684.

   119.     Bonamico M, Mariani P, Danesi HM, Crisogianni M, Failla P, Gemme G, et al. Prevalence and clinical picture of celiac disease in italian down syndrome patients: a multicenter study. J Pediatr Gastroenterol Nutr. 2001;33:139-143.

   120.     Carnicer J, Farre C, Varea V, Vilar P, Moreno J, Artigas J. Prevalence of coeliac disease in Down's syndrome. Eur J Gastroenterol Hepatol. 2001;13:263-267.

   121.     Cogulu O, Ozkinay F, Gunduz C, Cankaya T, Aydogdu S, Ozgenc F, et al. Celiac disease in children with Down syndrome: importance of follow-up and serologic screening. Pediatr Int. 2003;45:395-399.

   122.     Csizmadia CG, Mearin ML, Oren A, Kromhout A, Crusius JB, von Blomberg BM, et al. Accuracy and cost-effectiveness of a new strategy to screen for celiac disease in children with Down syndrome. J Pediatr. 2000;137:756-761.

   123.     Wouters J, Weijerman ME, van Furth AM, Schreurs MW, Crusius JB, von Blomberg BM, et al. Prospective human leukocyte antigen, endomysium immunoglobulin A antibodies, and transglutaminase antibodies testing for celiac disease in children with Down syndrome. J Pediatr. 2009;154:239-242.

   124.     Rostom A, Dube C, Cranney A, Saloojee N, Sy R, Garritty C, et al. Evidence Report/Technology Assesment No.104. Rockville: Agency for Healthcare Research and Quality.; 2004.

   125.     Shamaly H, Hartman C, Pollack S, Hujerat M, Katz R, Gideoni O, et al. Tissue transglutaminase antibodies are a useful serological marker for the diagnosis of celiac disease in patients with Down syndrome. J Pediatr Gastroenterol Nutr. 2007;44:583-586.

   126.     Mulder C. CBO-richtlijn Coeliakie en Dermatitis Herpetiformis. Haarlem: Nederlandse Vereniging van Maag-Darm-Leverartsen; 2008.

   127.     Hill I, Dirks M, Liptak G. Guidelines for the Diagnosis and treatment of celiac disease in children: recommendation of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2005;40:1-19.

   128.     Weijerman ME, van Furth AM, van dM, van Weissenbruch MM, Rammeloo L, Broers CJ, et al. Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome. Eur J Pediatr. 2010.

   129.     De Rubens FJ, del Pozzo MB, Pablos Hach JL, Calderon JC, Castrejon UR. [Heart malformations in children with Down syndrome]. Rev Esp Cardiol. 2003;56:894-899.

   130.     Freeman SB, Bean LH, Allen EG, Tinker SW, Locke AE, Druschel C, et al. Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project. Genet Med. 2008;10:173-180.

   131.     Jacobs EG, Leung MP, Karlberg J. Distribution of symptomatic congenital heart disease in Hong Kong. Pediatr Cardiol. 2000;21:148-157.

   132.     Jaiyesimi O, Baichoo V. Cardiovascular malformations in Omani Arab children with Down's syndrome. Cardiol Young. 2007;17:166-171.

   133.     Wells GL, Barker SE, Finley SC, Colvin EV, Finley WH. Congenital heart disease in infants with Down's syndrome. South Med J. 1994;87:724-727.

   134.     McElhinney DB, Straka M, Goldmuntz E, Zackai EH. Correlation between abnormal cardiac physical examination and echocardiographic findings in neonates with Down syndrome. Am J Med Genet. 2002;113:238-241.

   135.     Wren C, Richmond S, Donaldson L. Presentation of congenital heart disease in infancy: implications for routine examination. Arch Dis Child Fetal Neonatal Ed. 1999;80:F49-F53.

   136.     Kortenhorst MS, Hazekamp MG, Rammeloo LA, Schoof PH, Ottenkamp J. [Complete atrioventricular septal defect in children with Down's syndrome: good results of surgical correction at younger and younger ages]. Ned Tijdschr Geneeskd. 2005;149:589-593.

   137.     Lange R, Guenther T, Busch R, Hess J, Schreiber C. The presence of Down syndrome is not a risk factor in complete atrioventricular septal defect repair. J Thorac Cardiovasc Surg. 2007;134:304-310.

   138.     Vis JC, Duffels MG, Winter MM, Weijerman ME, Cobben JM, et al. Down syndrome: a cardiovascular perspective. J Intellect Disabil Res. 2009;53:419-425.

   139.     Frid C, Drott P, Otterblad OP, Sundelin C, Anneren G. Maternal and neonatal factors and mortality in children with Down syndrome born in 1973-1980 and 1995-1998. Acta Paediatr. 2004;93:106-112.

   140.     Wahab AA, Bener A, Sandridge AL, Hoffmann GF. The pattern of Down syndrome among children in Qatar: a population-based study. Birth Defects Res A Clin Mol Teratol. 2006;76:609-612.

   141.     Shah PS, Hellmann J, Adatia I. Clinical characteristics and follow up of Down syndrome infants without congenital heart disease who presented with persistent pulmonary hypertension of newborn. J Perinat Med. 2004;32:168-170.

   142.     Walsh-Sukys MC, Tyson JE, Wright LL, Bauer CR, Korones SB, Stevenson DK, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics. 2000;105:14-20.

   143.     Cua CL, Blankenship A, North AL, Hayes J, Nelin LD. Increased incidence of idiopathic persistent pulmonary hypertension in Down syndrome neonates. Pediatr Cardiol. 2007;28:250-254.

   144.     Hilton JM, Fitzgerald DA, Cooper DM. Respiratory morbidity of hospitalized children with Trisomy 21. J Paediatr Child Health. 1999;35:383-386.

   145.     Bloemers BL, van Furth AM, Weijerman ME, Gemke RJ, Broers CJ, van den EK, et al. Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis--a prospective birth-cohort study. Pediatrics. 2007;120:e1076-e1081.

   146.     Bloemers BL, van Furth AM, Weijerman ME, Gemke RJ, Broers CJ, Kimpen JL, et al. High incidence of recurrent wheeze in children with down syndrome with and without previous respiratory syncytial virus lower respiratory tract infection. Pediatr Infect Dis J. 2010;29:39-42.

   147.     So SA, Urbano RC, Hodapp RM. Hospitalizations of infants and young children with Down syndrome: evidence from inpatient person-records from a statewide administrative database. J Intellect Disabil Res. 2007;51:1030-1038.

   148.     Doul I. Repiratory disorders in Down's syndrome: overview with diagnostic and treatment options. Down's Syndrome Medical Interest Group 2002. beschikbaar op http:www.dsmig.org.uk/library./articles geraadpleegd augustus. 2010.

   149.     Bertrand P, Navarro H, Caussade S, Holmgren N, Sanchez I. Airway anomalies in children with Down syndrome: endoscopic findings. Pediatr Pulmonol. 2003;36:137-141.

   150.     Biko DM, Schwartz M, Anupindi SA, Altes TA. Subpleural lung cysts in Down syndrome: prevalence and association with coexisting diagnoses. Pediatr Radiol. 2008;38:280-284.

   151.     Cooney TP, Thurlbeck WM. Pulmonary hypoplasia in Down's syndrome. N Engl J Med. 1982;307:1170-1173.

   152.     Schieve LA, Boulet SL, Boyle C, Rasmussen SA, Schendel D. Health of children 3 to 17 years of age with Down syndrome in the 1997-2005 national health interview survey. Pediatrics. 2009;123:e253-e260.

   153.     Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D. Cancers and immune related diseases associated with Down's syndrome: a record linkage study. Arch Dis Child. 2004;89:1014-1017.

   154.     Forni GL, Rasore-Quartino A, Acutis MS, Strigini P. Incidence of bronchial asthma in Down syndrome. J Pediatr. 1990;116:487-488.

   155.     Mannan SE, Yousef E, Hossain J. Prevalence of positive skin prick test results in children with Down syndrome: a case-control study. Ann Allergy Asthma Immunol. 2009;102:205-209.

   156.     Kusters MA, Verstegen RH, Gemen EF, de VE. Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol. 2009;156:189-193.

   157.     de Hingh YC, van d, V, Gemen EF, Mulder AB, Hop WC, Brus F, et al. Intrinsic abnormalities of lymphocyte counts in children with down syndrome. J Pediatr. 2005;147:744-747.

   158.     Kusters MA, Gemen EF, Verstegen RH, Wever PC, de VE. Both normal memory counts and decreased naive cells favor intrinsic defect over early senescence of Down syndrome T-lymphocytes. Pediatr Res. 2010.

   159.     Verstegen RH, Kusters MA, Gemen EF, de VE. Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help. Pediatr Res. 2010.

   160.     Li VS, Mattina T, Mauro L, Bianca S, Anfuso S, Ursino A, et al. Safety and effectiveness of an acellular pertussis vaccine in subjects with Down's syndrome. Childs Nerv Syst. 1996;12:100-102.

   161.     Costa-Carvalho BT, Martinez RM, Dias AT, Kubo CA, Barros-Nunes P, Leiva L, et al. Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients. Braz J Med Biol Res. 2006;39:1587-1592.

   162.     Philip R, Berger AC, McManus NH, Warner NH, Peacock MA, Epstein LB. Abnormalities of the in vitro cellular and humoral responses to tetanus and influenza antigens with concomitant numerical alterations in lymphocyte subsets in Down syndrome (trisomy 21). J Immunol. 1986;136:1661-1667.

   163.     Vries de E. Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists. Clin Exp Immunol. 2006;145:204-214.

   164.     van Ditzhuijsen TJ, Kleijnen FM, Rijntjes PJ, van Loon AM, Yap SH. The prevalence of serological markers, hepatitis B virus DNA and elevated serum amino transferase values in institutionalized mentally handicapped males and females: an epidemiological study of HBV infection in residents with Down's syndrome or other forms of mental deficiency. Eur J Epidemiol. 1988;4:349-356.

   165.     Ahman L, Back E, Bensch K, Olcen P. Non-efficacy of low-dose intradermal vaccination against hepatitis B in Down's syndrome. Scand J Infect Dis. 1993;25:16-23.

   166.     van Trotsenburg AS, Heymans HS, Tijssen JG, de Vijlder JJ, Vulsma T. Comorbidity, hospitalization, and medication use and their influence on mental and motor development of young infants with Down syndrome. Pediatrics. 2006;118:1633-1639.

   167.     Garrison MM, Jeffries H, Christakis DA. Risk of death for children with down syndrome and sepsis. J Pediatr. 2005;147:748-752.

   168.     Juj H, Emery H. The arthropathy of Down syndrome: an underdiagnosed and under-recognized condition. J Pediatr. 2009;154:234-238.

   169.     Gillespie KM, Dix RJ, Williams AJ, Newton R, Robinson ZF, Bingley PJ, et al. Islet autoimmunity in children with Down's syndrome. Diabetes. 2006;55:3185-3188.

   170.     Nisihara RM, Skare TL, Silva MB, Messias-Reason IT, Oliveira NP, Fiedler PT, et al. High positivity of anti-CCP antibodies in patients with Down syndrome. Clin Rheumatol. 2007;26:2031-2035.

   171.     Requena-Silla Y, Rosenfield CG, Miller LC. Antiphospholipid antibodies and Down syndrome: a case series. J Pediatr Hematol Oncol. 2002;24:575-578.

   172.     Soderbergh A, Gustafsson J, Ekwall O, Hallgren A, Nilsson T, Kampe O, et al. Autoantibodies linked to autoimmune polyendocrine syndrome type I are prevalent in Down syndrome. Acta Paediatr. 2006;95:1657-1660.

   173.     Ramos Rosa Utiyama de S, Nisihara RM, Nass FR, Oliveira NP, Fiedler PT, de Messias-Reason IT. Autoantibodies in patients with Down syndrome: early senescence of the immune system or precocious markers for immunological diseases? J Paediatr Child Health. 2008;44:182-186.

   174.     Zwaan MC, Reinhardt D, Hitzler J, Vyas P. Acute leukemias in children with Down syndrome. Pediatr Clin North Am. 2008;55:53-70, x.

   175.     Henry E, Walker D, Wiedmeier SE, Christensen RD. Hematological abnormalities during the first week of life among neonates with Down syndrome: data from a multihospital healthcare system. Am J Med Genet A. 2007;143:42-50.

   176.     van Trotsenburg AS, Vulsma T, van Santen HM, Cheung W, de Vijlder JJ. Lower neonatal screening thyroxine concentrations in down syndrome newborns. J Clin Endocrinol Metab. 2003;88:1512-1515.

   177.     Fort P, Lifshitz F, Bellisario R, Davis J, Lanes R, Pugliese M, et al. Abnormalities of thyroid function in infants with Down syndrome. J Pediatr. 1984;104:545-549.

   178.     Kempers MJ, Lanting CI, van Heijst AF, van Trotsenburg AS, Wiedijk BM, de Vijlder JJ, et al. Neonatal screening for congenital hypothyroidism based on thyroxine, thyrotropin, and thyroxine-binding globulin measurement: potentials and pitfalls. J Clin Endocrinol Metab. 2006;91:3370-3376.

   179.     van Trotsenburg AS, Kempers MJ, Endert E, Tijssen JG, de Vijlder JJ, Vulsma T. Trisomy 21 causes persistent congenital hypothyroidism presumably of thyroidal origin. Thyroid. 2006;16:671-680.

   180.     Hunter I, Greene SA, MacDonald TM, Morris AD. Prevalence and aetiology of hypothyroidism in the young. Arch Dis Child. 2000;83:207-210.

   181.     van Trotsenburg AS. Early development and the thyroid hormone state in Down syndrome. Amsterdam: University of Amsterdam; 2006.

   182.     Rallison ML, Dobyns BM, Keating FR, Rall JE, Tyler FH. Occurrence and natural history of chronic lymphocytic thyroiditis in childhood. J Pediatr. 1975;86:675-682.

   183.     Goday-Arno A, Cerda-Esteva M, Flores-Le-Roux JA, Chillaron-Jordan JJ, Corretger JM, Cano-Perez JF. Hyperthyroidism in a population with Down syndrome (DS). Clin Endocrinol (Oxf). 2009;71:110-114.

   184.     Lavard L, Ranlov I, Perrild H, Andersen O, Jacobsen BB. Incidence of juvenile thyrotoxicosis in Denmark, 1982-1988. A nationwide study. Eur J Endocrinol. 1994;130:565-568.

   185.     Wong GW, Cheng PS. Increasing incidence of childhood Graves' disease in Hong Kong: a follow-up study. Clin Endocrinol (Oxf). 2001;54:547-550.

   186.     LaFranchi S, Hanna C. Graves' disease in the neonatal period and childhood. In: Braver-Man L, editor. The Thyroid. A Fundamental and Clinical Text. 9th ed. Philadelphia: Lippincott Williams&Wilkins; 2005. 1049-1059.

   187.     Gruneiro de PL, Chiesa A, Bastida MG, Alonso G, Finkielstain G, Heinrich JJ. Thyroid dysfunction and high thyroid stimulating hormone levels in children with Down's syndrome. J Pediatr Endocrinol Metab. 2002;15:1543-1548.

   188.     Rubello D, Pozzan GB, Casara D, Girelli ME, Boccato S, Rigon F, et al. Natural course of subclinical hypothyroidism in Down's syndrome: prospective study results and therapeutic considerations. J Endocrinol Invest. 1995;18:35-40.

   189.     Crino A, Ciampalini P, DiGilio M, Obregon M, Giannotti A, Borrelli P. Abnormal thyro-tropin secretion in Down's syndrome. In: Castells S, Wisniewski K, editors. Growth hormone treatment in Down's syndrome. John Wiley and sons; 1993. 101-109.

   190.     Castro L, Linares Garcia-Valdecasas R. A thyroid function study in subjects with Down's syndrome. Aten Primaria. 1999;23:87-90.

   191.     American Academy of Pediatrics: Health supervision for children with Down syndrome. Pediatrics. 2001;107:442-449.

   192.     Prasher V, Haque MS. Misdiagnosis of thyroid disorders in down syndrome: time to re-examine the myth? Am J Ment Retard. 2005;110:23-27.

   193.     Brown R. The thyroid. In: Brook C, editor. Brook's Clinical Pediatric Endocrinology. 6th ed. Oxford: Blackwell Publishing; 2009. 250-282.

   194.     Clement-de Boers A, Bongers-Schokking J, van Trotsenburg A. Argumenten voor en tegen thyroxine behandeling van jonge kinderen met Down syndroom van de neonatale periode tot de leeftijd van 2 jaar. SEK; 2008.

   195.     Bergholdt R, Eising S, Nerup J, Pociot F. Increased prevalence of Down's syndrome in individuals with type 1 diabetes in Denmark: A nationwide population-based study. Diabetologia. 2006;49:1179-1182.

   196.     Ohyama Y, Utsugi T, Uchiyama T, Hanaoka T, Tomono S, Kurabayashi M. Prevalence of diabetes in adult patients with Down's syndrome living in a residential home. Diabetes Care. 2000;23:705-706.

   197.     Bergholdt R, Nerup J, Pociot F. Fine mapping of a region on chromosome 21q21.11-q22.3 showing linkage to type 1 diabetes. J Med Genet. 2005;42:17-25.

   198.     Cronk C, Crocker AC, Pueschel SM, Shea AM, Zackai E, Pickens G, et al. Growth charts for children with Down syndrome: 1 month to 18 years of age. Pediatrics. 1988;81:102-110.

   199.     Cremers MJ, Tweel van der  I, Boersma B, Wit JM, Zonderland M. Growth curves of Dutch children with Down's syndrome. J Intellect Disabil Res. 1996;40 ( Pt 5):412-420.

   200.     van Buuren S., van Wouwe JP. WHO Child Growth Standards in action. Arch Dis Child. 2008;93:549-551.

   201.     Gameren-Oosterom van HBM. Downsyndroom Groeistudie. Leiden: TNO; 2010.

   202.     Talma H, Schönbeck Y, Bakker B, Hirasing RA, Buuren van S. Groeidiagrammen 2010: handleiding bij het meten en wegen van kinderen en het invullen van groeidiagrammen. Leiden: TNO Kwaliteit van Leven; 2010.

   203.     Hermanussen M, Cole J. The calculation of target height reconsidered. Horm Res. 2003;59:180-183.

   204.     Fredriks AM, Buuren van S, Burgmeijer RJ, Meulmeester JF, Beuker RJ, Brugman E, et al. Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res. 2000;47:316-323.

   205.     Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320:1240-1243.

   206.     Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292-295.

   207.     Fleisch AF, Agarwal N, Roberts MD, Han JC, Theim KR, Vexler A, et al. Influence of serum leptin on weight and body fat growth in children at high risk for adult obesity. J Clin Endocrinol Metab. 2007;92:948-954.

   208.     Magge SN, O'Neill KL, Shults J, Stallings VA, Stettler N. Leptin levels among prepubertal children with Down syndrome compared with their siblings. J Pediatr. 2008;152:321-326.

   209.     Arnell H, Gustafsson J, Ivarsson SA, Anneren G. Growth and pubertal development in Down syndrome. Acta Paediatr. 1996;85:1102-1106.

   210.     Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44:291-303.

   211.     Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45:13-23.

   212.     Burke LM, Kalpakjian CZ, Smith YR, Quint EH. Gynecologic issues of adolescents with Down syndrome, autism, and cerebral palsy. J Pediatr Adolesc Gynecol. 2010;23:11-15.

   213.     Goldstein H. Menarche, menstruation, sexual relations and contraception of adolescent females with Down syndrome. Eur J Obstet Gynecol Reprod Biol. 1988;27:343-349.

   214.     Scola PS, Pueschel SM. Menstrual cycles and basal body temperature curves in women with Down syndrome. Obstet Gynecol. 1992;79:91-94.

   215.     Bauer J, Isojarvi JI, Herzog AG, Reuber M, Polson D, Tauboll E, et al. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatry. 2002;73:121-125.

   216.     Quint EH. Menstrual issues in adolescents with physical and developmental disabilities. Ann N Y Acad Sci. 2008;1135:230-236.

   217.     Cohen WI. Current dilemmas in Down syndrome clinical care: celiac disease, thyroid disorders, and atlanto-axial instability. Am J Med Genet C Semin Med Genet. 2006;142C:141-148.

   218.     Zuhlke C, Thies U, Braulke I, Reis A, Schirren C. Down syndrome and male fertility: PCR-derived fingerprinting, serological and andrological investigations. Clin Genet. 1994;46:324-326.

   219.     Hsiang YH, Berkovitz GD, Bland GL, Migeon CJ, Warren AC. Gonadal function in patients with Down syndrome. Am J Med Genet. 1987;27:449-458.

   220.     Murphy NA, Elias ER. Sexuality of children and adolescents with developmental disabilities. Pediatrics. 2006;118:398-403.

   221.     Servais L. Sexual health care in persons with intellectual disabilities. Ment Retard Dev Disabil Res Rev. 2006;12:48-56.

   222.     MEE Midden-Holland; www.meemiddenholland.nl; Geraadpleegd augustus 2010. 2010.

   223.     Ministerie van Volksgezondheid, Welzijn en Sport; www.rijksoverheid.nl/vws; Geraadpleegd augustus 2010.

   224.     McPherson B, Lai SP, Leung KK, Ng IH. Hearing loss in Chinese school children with Down syndrome. Int J Pediatr Otorhinolaryngol. 2007;71:1905-1915.

   225.     Maroudias N, Economides J, Christodoulou P, Helidonis E. A study on the otoscopical and audiological findings in patients with Down's syndrome in Greece. Int J Pediatr Otorhinolaryngol. 1994;29:43-49.

   226.     Dahle AJ, McCollister FP. Hearing and otologic disorders in children with Down syndrome. Am J Ment Defic. 1986;90:636-642.

   227.     Fulton RT, Lloyd LL. Hearing impairment in a population of children with Down's syndrome. Am J Ment Defic. 1968;73:298-302.

   228.     Meuwese-Jongejeugd A, Vink M, van ZB, Verschuure H, Eichhorn E, Koopman D, et al. Prevalence of hearing loss in 1598 adults with an intellectual disability: cross-sectional population based study. Int J Audiol. 2006;45:660-669.

   229.     Creavin AL, Brown RD. Ophthalmic abnormalities in children with Down syndrome. J Pediatr Ophthalmol Strabismus. 2009;46:76-82.

   230.     Haargaard B, Fledelius HC. Down's syndrome and early cataract. Br J Ophthalmol. 2006;90:1024-1027.

   231.     Tsiaras WG, Pueschel S, Keller C, Curran R, Giesswein S. Amblyopia and visual acuity in children with Down's syndrome. Br J Ophthalmol. 1999;83:1112-1114.

   232.     Akinci A, Oner O, Bozkurt OH, Guven A, Degerliyurt A, Munir K. Refractive errors and strabismus in children with Ddown syndrome: a controlled study. J Pediatr Ophthalmol Strabismus. 2009;46:83-86.

   233.     Stephen E, Dickson J, Kindley AD, Scott CC, Charleton PM. Surveillance of vision and ocular disorders in children with Down syndrome. Dev Med Child Neurol. 2007;49:513-515.

   234.     Liza-Sharmini AT, Azlan ZN, Zilfalil BA. Ocular findings in Malaysian children with Down syndrome. Singapore Med J. 2006;47:14-19.

   235.     Wong V, Ho D. Ocular abnormalities in Down syndrome: an analysis of 140 Chinese children. Pediatr Neurol. 1997;16:311-314.

   236.     Fimiani F, Iovine A, Carelli R, Pansini M, Sebastio G, Magli A. Incidence of ocular pathologies in Italian children with Down syndrome. Eur J Ophthalmol. 2007;17:817-822.

   237.     Merrick J, Koslowe K. Refractive errors and visual anomalies in Down syndrome. Downs Syndr Res Pract. 2001;6:131-133.

   238.     Gonzalez V, I, Ferrer NC, Ferrer NE, Pueyo SM, Bueno LJ, Vicente AE. [Ophthalmological exploration of children with Down's syndrome. Main results and comparison with a control group]. An Esp Pediatr. 1996;45:137-139.

   239.     Kim JH, Hwang JM, Kim HJ, Yu YS. Characteristic ocular findings in Asian children with Down syndrome. Eye. 2002;16:710-714.

   240.     da Cunha RP, Moreira JB. Ocular findings in Down's syndrome. Am J Ophthalmol. 1996;122:236-244.

   241.     Rahi JS, Dezateux C. National cross sectional study of detection of congenital and infantile cataract in the United Kingdom: role of childhood screening and surveillance. The British Congenital Cataract Interest Group. BMJ. 1999;318:362-365.

   242.     Courage ML, Adams RJ, Reyno S, Kwa PG. Visual acuity in infants and children with Down syndrome. Dev Med Child Neurol. 1994;36:586-593.

   243.     John FM, Bromham NR, Woodhouse JM, Candy TR. Spatial vision deficits in infants and children with Down syndrome. Invest Ophthalmol Vis Sci. 2004;45:1566-1572.

   244.     Courage ML, Adams RJ, Hall EJ. Contrast sensitivity in infants and children with Down syndrome. Vision Res. 1997;37:1545-1555.

   245.     Little JA, Woodhouse JM, Lauritzen JS, Saunders KJ. Vernier acuity in Down syndrome. Invest Ophthalmol Vis Sci. 2009;50:567-572.

   246.     Little JA, Woodhouse JM, Lauritzen JS, Saunders KJ. The impact of optical factors on resolution acuity in children with Down syndrome. Invest Ophthalmol Vis Sci. 2007;48:3995-4001.

   247.     Cregg M, Woodhouse JM, Pakeman VH, Saunders KJ, Gunter HL, Parker M, et al. Accommodation and refractive error in children with Down syndrome: cross-sectional and longitudinal studies. Invest Ophthalmol Vis Sci. 2001;42:55-63.

   248.     Woodhouse JM, Cregg M, Gunter HL, Sanders DP, Saunders KJ, Pakeman VH, et al. The effect of age, size of target, and cognitive factors on accommodative responses of children with Down syndrome. Invest Ophthalmol Vis Sci. 2000;41:2479-2485.

   249.     Haugen OH, Hovding G, Lundstrom I. Refractive development in children with Down's syndrome: a population based, longitudinal study. Br J Ophthalmol. 2001;85:714-719.

   250.     Stewart RE, Woodhouse JM, Cregg M, Pakeman VH. Association between accommodative accuracy, hypermetropia, and strabismus in children with Down's syndrome. Optom Vis Sci. 2007;84:149-155.

   251.     Al-Bagdady M, Stewart RE, Watts P, Murphy PJ, Woodhouse JM. Bifocals and Down's syndrome: correction or treatment? Ophthalmic Physiol Opt. 2009;29:416-421.

   252.     Stewart RE, Margaret WJ, Trojanowska LD. In focus: the use of bifocal spectacles with children with Down's syndrome. Ophthalmic Physiol Opt. 2005;25:514-522.

   253.     Cregg M, Woodhouse JM, Stewart RE, Pakeman VH, Bromham NR, Gunter HL, et al. Development of refractive error and strabismus in children with Down syndrome. Invest Ophthalmol Vis Sci. 2003;44:1023-1030.

   254.     Yurdakul NS, Ugurlu S, Maden A. Strabismus in Down syndrome. J Pediatr Ophthalmol Strabismus. 2006;43:27-30.

   255.     Haugen OH, Hovding G. Strabismus and binocular function in children with Down syndrome. A population-based, longitudinal study. Acta Ophthalmol Scand. 2001;79:133-139.

   256.     Jacobs SM, Green-Simms A, Diehl NN, Mohney BG. Long-term follow-up of acquired nonaccommodative esotropia in a population-based cohort. Ophthalmology. 2011;118:1170-1174.

   257.     Simonsz HJ, Kolling GH. Best age for surgery for infantile esotropia. Eur J Paediatr Neurol. 2011;15:205-208.

   258.     Yahalom C, Mechoulam H, Cohen E, Anteby I. Strabismus surgery outcome among children and young adults with Down syndrome. J AAPOS. 2010;14:117-119.

   259.     Wagner RS, Caputo AR, Reynolds RD. Nystagmus in Down's syndrome. Ophthalmology. 1990;97:1439-1444.

   260.     Verbuch-Heller L, Dell'Osso LF, Jacobs JB, Remler BF. Latent and congenital nystagmus in Down syndrome. J Neuroophthalmol. 1999;19:166-172.

   261.     Bagheri A, Aletaha M, Abrishami M. The effect of horizontal rectus muscle surgery on clinical and eye movement recording indices in infantile nystagmus syndrome. Strabismus. 2010;18:58-64.

   262.     Roizen NJ, Mets MB, Blondis TA. Ophthalmic disorders in children with Down syndrome. Dev Med Child Neurol. 1994;36:594-600.

   263.     Liyanage S, Barnes J. The eye and Down's syndrome. Br J Hosp Med (Lond). 2008;69:632-634.

   264.     Salvio CC, Hida WT, Filho JV, Cunha M, dos Santos AJ. [Congenital epiphora in patients with Down syndrome]. Arq Bras Oftalmol. 2007;70:423-427.

   265.     Doyle SJ, Bullock J, Gray C, Spencer A, Cunningham C. Emmetropisation, axial length, and corneal topography in teenagers with Down's syndrome. Br J Ophthalmol. 1998;82:793-796.

   266.     Haugen OH, Hovding G, Eide GE. Biometric measurements of the eyes in teenagers and young adults with Down syndrome. Acta Ophthalmol Scand. 2001;79:616-625.

   267.     Vincent AL, Weiser BA, Cupryn M, Stein RM, Abdolell M, Levin AV. Computerized corneal topography in a paediatric population with Down syndrome. Clin Experiment Ophthalmol. 2005;33:47-52.

   268.     Nordan LT. Keratoconus: diagnosis and treatment. Int Ophthalmol Clin. 1997;37:51-63.

   269.     Grunauer-Kloevekorn C, Duncker GI. [Keratoconus: epidemiology, risk factors and diagnosis]. Klin Monbl Augenheilkd. 2006;223:493-502.

   270.     Richtlijnen voor diagnostiek en behandeling van visuele stoornissen bij verstandelijk gehandicapten. Utrecht: Nederlandse Vereniging voor Artsen voor Verstandelijk Gehandicapten.; 1997.

   271.     Mazzotta C, Balestrazzi A, Traversi C, Baiocchi S, Caporossi T, Tommasi C, et al. Treatment of progressive keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen: ultrastructural analysis by Heidelberg Retinal Tomograph II in vivo confocal microscopy in humans. Cornea. 2007;26:390-397.

   272.     Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol. 2006;17:356-360.

   273.     Faschinger C, Kleinert R, Wedrich A. [Corneal melting in both eyes after simultaneous corneal cross-linking in a patient with keratoconus and Down syndrome]. Ophthalmologe. 2010;107:951-955.

   274.     Russell-Eggitt I. Childhood Glaucoma. In: Taylor D, editor. Pediatric opthalmology. 2nd ed.  Wiley-Blackwell; 1997.

   275.     Yokoyama T, Tamura H, Tsukamoto H, Yamane K, Mishima HK. Prevalence of glaucoma in adults with Down's syndrome. Jpn J Ophthalmol. 2006;50:274-276.

   276.     http://www.dsmig.org.uk/library/articles/keypoints-vision.html geraadpleegd augustus. 2010.

   277.     Haugen OH, Hovding G, Riise R. [Ocular changes in Down syndrome]. Tidsskr Nor Laegeforen. 2004;124:186-188.

   278.     http://www.cardiff.ac.uk/optom/eyeclinic/downssyndromegroup/ downssyndromemain.html  Geraadpleegd augustus 2010.

   279.     Maatta T, Kaski M, Taanila A, Keinanen-Kiukaanniemi S, Iivanainen M. Sensory impairments and health concerns related to the degree of intellectual disability in people with Down syndrome. Downs Syndr Res Pract. 2006;11:78-83.

   280.     Hassmann E, Skotnicka B, Midro AT, Musiatowicz M. Distortion products otoacoustic emissions in diagnosis of hearing loss in Down syndrome. Int J Pediatr Otorhinolaryngol. 1998;45:199-206.

   281.     Shott SR. Down syndrome: common otolaryngologic manifestations. Am J Med Genet C Semin Med Genet. 2006;142C:131-140.

   282.     Chen YJ, Fang PC. Sensory evoked potentials in infants with Down syndrome. Acta Paediatr. 2005;94:1615-1618.

   283.     Blaser S, Propst EJ, Martin D, Feigenbaum A, James AL, Shannon P, et al. Inner ear dysplasia is common in children with Down syndrome (trisomy 21). Laryngoscope. 2006;116:2113-2119.

   284.     Widen JE, Folsom RC, Thompson G, Wilson WR. Auditory brainstem responses in young adults with Down syndrome. Am J Ment Defic. 1987;91:472-479.

   285.     Venail F, Gardiner Q, Mondain M. ENT and speech disorders in children with Down's syndrome: an overview of pathophysiology, clinical features, treatments, and current management. Clin Pediatr (Phila). 2004;43:783-791.

   286.     Draaiboek neonatale gehoorscreening: http//www.rivm.nl/pns/gehoorscreening/  geraadpleegd augustus. 2010.

   287.     Evenhuis h. Richtlijnen voor diagnostiek en behandeling van slechthorenheid bij verstandelijk gehandicapten. Utrecht: Nederlandse Vereniging voor Artsen voor Verstandelijk Gehandicapten.; 1995.

   288.     Amerikaanse richtlijn 'Health supervision in children with Down Syndrome: http.www.aappolicy.aappublications.org  geraadpleegd augustus. 2010.

   289.     Engelse richtlijn voor gehoorproblemen bij kinderen met Down Syndroom  http://www.dsmig.org.uk/library/articles  geraadpleegd augustus. 2010.

   290.     Notitie jeugdgezondheidszorg "speciale zorg voor speciale kinderen" http://ajn.artsennet.nl  geraadpleegd augustus. 2010.

   291.     Iino Y, Imamura Y, Harigai S, Tanaka Y. Efficacy of tympanostomy tube insertion for otitis media with effusion in children with Down syndrome. Int J Pediatr Otorhinolaryngol. 1999;49:143-149.

   292.     Selikowitz M. Short-term efficacy of tympanostomy tubes for secretory otitis media in children with Down syndrome. Dev Med Child Neurol. 1993;35:511-515.

   293.     Shott SR, Joseph A, Heithaus D. Hearing loss in children with Down syndrome. Int J Pediatr Otorhinolaryngol. 2001;61:199-205.

   294.     Fitzgerald DA, Paul A, Richmond C. Severity of obstructive apnoea in children with Down syndrome who snore. Arch Dis Child. 2007;92:423-425.

   295.     Ng DK, Hui HN, Chan CH, Kwok KL, Chow PY, Cheung JM, et al. Obstructive sleep apnoea in children with Down syndrome. Singapore Med J. 2006;47:774-779.

   296.     Shott SR, Amin R, Chini B, Heubi C, Hotze S, Akers R. Obstructive sleep apnea: Should all children with Down syndrome be tested? Arch Otolaryngol Head Neck Surg. 2006;132:432-436.

   297.     de Miguel-Diez J, Villa-Asensi JR, varez-Sala JL. Prevalence of sleep-disordered breathing in children with Down syndrome: polygraphic findings in 108 children. Sleep. 2003;26:1006-1009.

   298.     Dyken ME, Lin-Dyken DC, Poulton S, Zimmerman MB, Sedars E. Prospective polysomnographic analysis of obstructive sleep apnea in down syndrome. Arch Pediatr Adolesc Med. 2003;157:655-660.

   299.     Guimaraes CV, Donnelly LF, Shott SR, Amin RS, Kalra M. Relative rather than absolute macroglossia in patients with Down syndrome: implications for treatment of obstructive sleep apnea. Pediatr Radiol. 2008;38:1062-1067.

   300.     Shott SR, Donnelly LF. Cine magnetic resonance imaging: evaluation of persistent airway obstruction after tonsil and adenoidectomy in children with Down syndrome. Laryngoscope. 2004;114:1724-1729.

   301.     Donnelly LF, Shott SR, LaRose CR, Chini BA, Amin RS. Causes of persistent obstructive sleep apnea despite previous tonsillectomy and adenoidectomy in children with down syndrome as depicted on static and dynamic cine MRI. AJR Am J Roentgenol. 2004;183:175-181.

   302.     Merrell JA, Shott SR. OSAS in Down syndrome: T&A versus T&A plus lateral pharyngoplasty. Int J Pediatr Otorhinolaryngol. 2007;71:1197-1203.

   303.     Fischer-Brandies H, Schmid RG, Fischer-Brandies E. Craniofacial development in patients with Down's syndrome from birth to 14 years of age. Eur J Orthod. 1986;8:35-42.

   304.     Oliveira AC, Paiva SM, Campos MR, Czeresnia D. Factors associated with malocclusions in children and adolescents with Down syndrome. Am J Orthod Dentofacial Orthop. 2008;133:489-8.

   305.     Fischer-Brandies H. Cephalometric comparison between children with and without Down's syndrome. Eur J Orthod. 1988;10:255-263.

   306.     Quintanilla JS, Biedma BM, Rodriguez MQ, Mora MT, Cunqueiro MM, Pazos MA. Cephalometrics in children with Down's syndrome. Pediatr Radiol. 2002;32:635-643.

   307.     Proffit W, Fields H. Contemporary orthodontics. Third ed. St Louis: Mosby; 2004.

   308.     Van der Linden F. Gebitsontwikkeling (deel I). Alphen aan den Rijn: Stafleu & Tholen; 1979.

   309.     Ondarza A, Jara L, Bertonati MI, Blanco R. Tooth malalignments in Chilean children with Down syndrome. Cleft Palate Craniofac J. 1995;32:188-193.

   310.     Harrison JE, Ashby D. Orthodontic treatment for posterior crossbites. Cochrane Database Syst Rev. 2001;CD000979.

   311.     Lagravere MO, Major PW, Flores-Mir C. Long-term dental arch changes after rapid maxillary expansion treatment: a systematic review. Angle Orthod. 2005;75:155-161.

   312.     Carlstedt K, Henningsson G, Dahllof G. A four-year longitudinal study of palatal plate therapy in children with Down syndrome: effects on oral motor function, articulation and communication preferences. Acta Odontol Scand. 2003;61:39-46.

   313.     Asokan S, Muthu MS, Sivakumar N. Oral findings of Down syndrome children in Chennai city, India. Indian J Dent Res. 2008;19:230-235.

   314.     Hennequin M, Faulks D, Veyrune JL, Bourdiol P. Significance of oral health in persons with Down syndrome: a literature review. Dev Med Child Neurol. 1999;41:275-283.

   315.     Chawla HS, Suri S, Utreja A. Is tongue thrust that develops during orthodontic treatment an unrecognized potential road block? J Indian Soc Pedod Prev Dent. 2006;24:80-83.

   316.     Shapira J, Stabholz A. A comprehensive 30-month preventive dental health program in a pre-adolescent population with Down's syndrome: a longitudinal study. Spec Care Dentist. 1996;16:33-37.

   317.     Smithpeter J, Covell D, Jr. Relapse of anterior open bites treated with orthodontic appliances with and without orofacial myofunctional therapy. Am J Orthod Dentofacial Orthop. 2010;137:605-614.

   318.     Backman B, Grever-Sjolander AC, Bengtsson K, Persson J, Johansson I. Children with Down syndrome: oral development and morphology after use of palatal plates between 6 and 48 months of age. Int J Paediatr Dent. 2007;17:19-28.

   319.     Lopez-Perez R, Borges-Yanez SA, Lopez-Morales P. Anterior open bite and speech disorders in children with Down syndrome. Angle Orthod. 2008;78:221-227.

   320.     Townsend GC. Tooth size in children and young adults with trisomy 21 (Down) syndrome. Arch Oral Biol. 1983;28:159-166.

   321.     Cohen MM, Sr., Cohen MM, Jr. The oral manifestations of trisomy G-1 (Down syndrome). Birth Defects Orig Artic Ser. 1971;7:241-251.

   322.     Desai SS. Down syndrome: a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84:279-285.

   323.     de Moraes ME, de Moraes LC, Dotto GN, Dotto PP, dos Santos LR. Dental anomalies in patients with Down syndrome. Braz Dent J. 2007;18:346-350.

   324.     Bell E, Townsend G, Wilson D, Kieser J, Hughes T. Effect of Down syndrome on the dimensions of dental crowns and tissues. Am J Hum Biol. 2001;13:690-698.

   325.     Shapira J, Chaushu S, Becker A. Prevalence of tooth transposition, third molar agenesis, and maxillary canine impaction in individuals with Down syndrome. Angle Orthod. 2000;70:290-296.

   326.     Reuland-Bosma W, Reuland MC, Bronkhorst E, Phoa KH. Patterns of tooth agenesis in patients with Down syndrome in relation to hypothyroidism and congenital heart disease: an aid for treatment planning. Am J Orthod Dentofacial Orthop. 2010;137:584-589.

   327.     Acerbi AG, de FC, de Magalhaes MH. Prevalence of numeric anomalies in the permanent dentition of patients with Down syndrome. Spec Care Dentist. 2001;21:75-78.

   328.     Polder BJ, Van't Hof MA, Van der Linden FP, Kuijpers-Jagtman AM. A meta-analysis of the prevalence of dental agenesis of permanent teeth. Community Dent Oral Epidemiol. 2004;32:217-226.

   329.     Endo T, Ozoe R, Yoshino S, Shimooka S. Hypodontia patterns and variations in craniofacial morphology in Japanese orthodontic patients. Angle Orthod. 2006;76:996-1003.

   330.     Endo T, Yoshino S, Ozoe R, Kojima K, Shimooka S. Association of advanced hypodontia and craniofacial morphology in Japanese orthodontic patients. Odontology. 2004;92:48-53.

   331.     van Wijk AJ, Tan SP. A numeric code for identifying patterns of human tooth agenesis: a new approach. Eur J Oral Sci. 2006;114:97-101.

   332.     Lustig JP, Yanko R, Zilberman U. Use of dental implants in patients with Down syndrome: a case report. Spec Care Dentist. 2002;22:201-204.

   333.     Karoussis IK, Kotsovilis S, Fourmousis I. A comprehensive and critical review of dental implant prognosis in periodontally compromised partially edentulous patients. Clin Oral Implants Res. 2007;18:669-679.

   334.     Bradley C, McAlister T. The oral health of children with Down syndrome in Ireland. Spec Care Dentist. 2004;24:55-60.

   335.     Cheng RH, Leung WK, Corbet EF, King NM. Oral health status of adults with Down syndrome in Hong Kong. Spec Care Dentist. 2007;27:134-138.

   336.     Amerongen AV, Veerman EC. Saliva--the defender of the oral cavity. Oral Dis. 2002;8:12-22.

   337.     Bell EJ, Kaidonis J, Townsend GC. Tooth wear in children with Down syndrome. Aust Dent J. 2002;47:30-35.

   338.     Sakellari D, Arapostathis KN, Konstantinidis A. Periodontal conditions and subgingival microflora in Down syndrome patients. A case-control study. J Clin Periodontol. 2005;32:684-690.

   339.     maral Loureiro AC, Oliveira CF, Eustaquio da CJ. The impact of periodontal disease on the quality of life of individuals with Down syndrome. Downs Syndr Res Pract. 2007;12:50-54.

   340.     Reuland-Bosma W. [Periodontal disease in Down's syndrome]. Ned Tijdschr Tandheelkd. 1990;97:468-471.

   341.     Amano A, Kishima T, Kimura S, Takiguchi M, Ooshima T, Hamada S, et al. Periodontopathic bacteria in children with Down syndrome. J Periodontol. 2000;71:249-255.

   342.     Reuland-Bosma W, van der Reijden WA, van Winkelhoff AJ. Absence of a specific subgingival microflora in adults with Down's syndrome. J Clin Periodontol. 2001;28:1004-1009.

   343.     Zigmond M, Stabholz A, Shapira J, Bachrach G, Chaushu G, Becker A, et al. The outcome of a preventive dental care programme on the prevalence of localized aggressive periodontitis in Down's syndrome individuals. J Intellect Disabil Res. 2006;50:492-500.

   344.     Chaushu S, Chaushu G, Zigmond M, Yefenof E, Stabholz A, Shapira J, et al. Age-dependent deficiency in saliva and salivary antibodies secretion in Down's syndrome. Arch Oral Biol. 2007;52:1088-1096.

   345.     Yoshihara T, Morinushi T, Kinjyo S, Yamasaki Y. Effect of periodic preventive care on the progression of periodontal disease in young adults with Down's syndrome. J Clin Periodontol. 2005;32:556-560.

   346.     Teitelbaum AP, Pochapski MT, Jansen JL, Sabbagh-Haddad A, Santos FA, Czlusniak GD. Evaluation of the mechanical and chemical control of dental biofilm in patients with Down syndrome. Community Dent Oral Epidemiol. 2009;37:463-467.

   347.     Zaldivar-Chiapa RM, rce-Mendoza AY, De LR-R, Caffesse RG, Solis-Soto JM. Evaluation of surgical and non-surgical periodontal therapies, and immunological status, of young Down's syndrome patients. J Periodontol. 2005;76:1061-1065.

   348.     Van der Velden. The Dutch periodontal screening index validation and its application in The Netherlands. J Clin Periodontol. 2009;36:1018-1024.

   349.     Lopez-Perez R, Lopez-Morales P, Borges-Yanez SA, Maupome G, Pares-Vidrio G. Prevalence of bruxism among Mexican children with Down syndrome. Downs Syndr Res Pract. 2007;12:45-49.

   350.     Lobbezoo F, Naeije M. [Etiology of bruxism: morphological, pathophysiological and psychological factors]. Ned Tijdschr Tandheelkd. 2000;107:275-280.

   351.     Arya R, Kabra M, Gulati S. Epilepsy in children with Down syndrome. Epileptic Disord. 2011;13:1-7.

   352.     Smigielska-Kuzia J, Sobaniec W, Kulak W, Bockowski L. Clinical and EEG features of epilepsy in children and adolescents in Down syndrome. J Child Neurol. 2009;24:416-420.

   353.     Eisermann MM, DeLaRaillere A, Dellatolas G, Tozzi E, Nabbout R, Dulac O, et al. Infantile spasms in Down syndrome--effects of delayed anticonvulsive treatment. Epilepsy Res. 2003;55:21-27.

   354.     Osborne JP, Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, et al. The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification. Epilepsia. 2010;51:2168-2174.

   355.     Ferlazzo E, Adjien CK, Guerrini R, Calarese T, Crespel A, Elia M, et al. Lennox-Gastaut syndrome with late-onset and prominent reflex seizures in trisomy 21 patients. Epilepsia. 2009;50:1587-1595.

   356.     Roach ES, Golomb MR, Adams R, Biller J, Daniels S, Deveber G, et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke. 2008;39:2644-2691.

   357.     de Borchgrave V, Saussu F, Depre A, De Berker DA. Moyamoya disease and Down syndrome: case report and review of the literature. Acta Neurol Belg. 2002;102:63-66.

   358.     Jea A, Smith ER, Robertson R, Scott RM. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization. Pediatrics. 2005;116:e694-e701.

   359.     Merrick J, Ezra E, Josef B, Hendel D, Steinberg DM, Wientroub S. Musculoskeletal problems in Down Syndrome European Paediatric Orthopaedic Society Survey: the Israeli sample. J Pediatr Orthop B. 2000;9:185-192.

   360.     Ohsawa T, Izawa T, Kuroki Y, Ohnari K. Follow-up study of atlanto-axial instability in Down's syndrome without separate odontoid process. Spine (Phila Pa 1976 ). 1989;14:1149-1153.

   361.     Cremers MJ, Beijer HJ. No relation between general laxity and atlantoaxial instability in children with Down syndrome. J Pediatr Orthop. 1993;13:318-321.

   362.     Livingstone B, Hirst P. Orthopedic disorders in school children with Down's syndrome with special reference to the incidence of joint laxity. Clin Orthop Relat Res. 1986;74-76.

   363.     Ali FE, Al-Bustan MA, Al-Busairi WA, Al-Mulla FA, Esbaita EY. Cervical spine abnormalities associated with Down syndrome. Int Orthop. 2006;30:284-289.

   364.     Pueschel SM, Scola FH, Tupper TB, Pezzullo JC. Skeletal anomalies of the upper cervical spine in children with Down syndrome. J Pediatr Orthop. 1990;10:607-611.

   365.     Olson JC, Bender JC, Levinson JE, Oestreich A, Lovell DJ. Arthropathy of Down syndrome. Pediatrics. 1990;86:931-936.

   366.     Concolino D, Pasquzzi A, Capalbo G, Sinopoli S, Strisciuglio P. Early detection of podiatric anomalies in children with Down syndrome. Acta Paediatr. 2006;95:17-20.

   367.     Prasher VP, Robinson L, Krishnan VH, Chung MC. Podiatric disorders among children with Down syndrome and learning disability. Dev Med Child Neurol. 1995;37:131-134.

   368.     Dugdale TW, Renshaw TS. Instability of the patellofemoral joint in Down syndrome. J Bone Joint Surg Am. 1986;68:405-413.

   369.     Mendez AA, Keret D, MacEwen GD. Treatment of patellofemoral instability in Down's syndrome. Clin Orthop Relat Res. 1988;148-158.

   370.     Bettuzzi C, Lampasi M, Magnani M, Donzelli O. Surgical treatment of patellar dislocation in children with Down syndrome: a 3- to 11-year follow-up study. Knee Surg Sports Traumatol Arthrosc. 2009;17:334-340.

   371.     Mizobuchi RR, Galbiatti JA, Quirici NF, Milani C, Fujiki EN, de Oliveira HC, et al. Ultrasonographic study of the femoro-patellar joint and its attachments in infants from birth to 24 months of age. Part II: children with Down syndrome. J Pediatr Orthop B. 2007;16:266-268.

   372.     Bennet GC, Rang M, Roye DP, Aprin H. Dislocation of the hip in trisomy 21. J Bone Joint Surg Br. 1982;64:289-294.

   373.     Shaw ED, Beals RK. The hip joint in Down's syndrome. A study of its structure and associated disease. Clin Orthop Relat Res. 1992;101-107.

   374.     Hresko MT, McCarthy JC, Goldberg MJ. Hip disease in adults with Down syndrome. J Bone Joint Surg Br. 1993;75:604-607.

   375.     Buzzi UH, Ulrich BD. Dynamic stability of gait cycles as a function of speed and system constraints. Motor Control. 2004;8:241-254.

   376.     Dietz FR, Albanese SA, Katz DA, Dobbs MB, Salamon PB, Schoenecker PL, et al. Slipped capital femoral epiphysis in down syndrome. J Pediatr Orthop. 2004;24:508-513.

   377.     Bosch P, Johnston CE, Karol L. Slipped capital femoral epiphysis in patients with Down syndrome. J Pediatr Orthop. 2004;24:271-277.

   378.     Milbrandt TA, Johnston CE. Down syndrome and scoliosis: a review of a 50-year experience at one institution. Spine. 2005;30:2051-2055.

   379.     Pueschel SM, Scola FH. Atlantoaxial instability in individuals with Down syndrome: epidemiologic, radiographic, and clinical studies. Pediatrics. 1987;80:555-560.

   380.     Ferguson RL, Putney ME, Allen BL, Jr. Comparison of neurologic deficits with atlanto-dens intervals in patients with Down syndrome. J Spinal Disord. 1997;10:246-252.

   381.     Pueschel SM, Herndon JH, Gelch MM, Senft KE, Scola FH, Goldberg MJ. Symptomatic atlantoaxial subluxation in persons with Down syndrome. J Pediatr Orthop. 1984;4:682-688.

   382.     Tredwell SJ, Newman DE, Lockitch G. Instability of the upper cervical spine in Down syndrome. J Pediatr Orthop. 1990;10:602-606.

   383.     Parfenchuck TA, Bertrand SL, Powers MJ, Drvaric DM, Pueschel SM, Roberts JM. Posterior occipitoatlantal hypermobility in Down syndrome: an analysis of 199 patients. J Pediatr Orthop. 1994;14:304-308.

   384.     Pueschel SM, Moon AC, Scola FH. Computerized tomography in persons with Down syndrome and atlantoaxial instability. Spine (Phila Pa 1976 ). 1992;17:735-737.

   385.     Nader-Sepahi A, Casey AT, Hayward R, Crockard HA, Thompson D. Symptomatic atlantoaxial instability in Down syndrome. J Neurosurg. 2005;103:231-237.

   386.     Roy M, Baxter M, Roy A. Atlantoaxial instability in Down syndrome--guidelines for screening and detection. J R Soc Med. 1990;83:433-435.

   387.     Cremers MJ, Bol E, Roos de F, Gijn van J. Risk of sports activities in children with Down's syndrome and atlantoaxial instability. Lancet. 1993;342:511-514.

   388.     Wellborn CC, Sturm PF, Hatch RS, Bomze SR, Jablonski K. Intraobserver reproducibility and interobserver reliability of cervical spine measurements. J Pediatr Orthop. 2000;20:66-70.

   389.     Selby KA, Newton RW, Gupta S, Hunt L. Clinical predictors and radiological reliability in atlantoaxial subluxation in Down's syndrome. Arch Dis Child. 1991;66:876-878.

   390.     Karol LA, Sheffield EG, Crawford K, Moody MK, Browne RH. Reproducibility in the measurement of atlanto-occipital instability in children with Down syndrome. Spine (Phila Pa 1976 ). 1996;21:2463-2467.

   391.     Birrer RB. The Special Olympics athlete: evaluation and clearance for participation. Clin Pediatr (Phila). 2004;43:777-782.

   392.     Brockmeyer D. Down syndrome and craniovertebral instability. Topic review and treatment recommendations. Pediatr Neurosurg. 1999;31:71-77.

   393.     Cohen WI. Atlantoaxial instability. What's next? Arch Pediatr Adolesc Med. 1998;152:119-122.

   394.     Pueschel SM. Should children with Down syndrome be screened for atlantoaxial instability? Arch Pediatr Adolesc Med. 1998;152:123-125.

   395.     Tassone JC, Duey-Holtz A. Spine concerns in the Special Olympian with Down syndrome. Sports Med Arthrosc. 2008;16:55-60.

   396.     Hata T, Todd MM. Cervical spine considerations when anesthetizing patients with Down syndrome. Anesthesiology. 2005;102:680-685.

   397.     Meitzner MC, Skurnowicz JA. Anesthetic considerations for patients with Down syndrome. AANA J. 2005;73:103-107.

   398.     Dourmishev A, Miteva L, Mitev V, Pramatarov K, Schwartz RA. Cutaneous aspects of Down syndrome. Cutis. 2000;66:420-424.

   399.     Barankin B, Guenther L. Dermatological manifestations of Down's syndrome. J Cutan Med Surg. 2001;5:289-293.

   400.     Schepis C, Barone C, Siragusa M, Pettinato R, Romano C. An updated survey on skin conditions in Down syndrome. Dermatology. 2002;205:234-238.

   401.     Madan V, Williams J, Lear JT. Dermatological manifestations of Down's syndrome. Clin Exp Dermatol. 2006;31:623-629.

   402.     Daneshpazhooh M, Nazemi TM, Bigdeloo L, Yoosefi M. Mucocutaneous findings in 100 children with Down syndrome. Pediatr Dermatol. 2007;24:317-320.

   403.     Butterworth T. Dermatologic disorders in institutionalized mental defectives. Birth Defects Orig Artic Ser. 1971;7:178-185.

   404.     Carter DM, Jegasothy BV. Alopecia areata and Down syndrome. Arch Dermatol. 1976;112:1397-1399.

   405.     Baccichetti C, Lenzini E, Pegoraro R. Down syndrome in the Belluno district (Veneto region, northeast Italy): age distribution and morbidity. Am J Med Genet Suppl. 1990;7:84-86.

   406.     Scherbenske JM, Benson PM, Rotchford JP, James WD. Cutaneous and ocular manifestations of Down syndrome. J Am Acad Dermatol. 1990;22:933-938.

   407.     Ercis M, Balci S, Atakan N. Dermatological manifestations of 71 Down syndrome children admitted to a clinical genetics unit. Clin Genet. 1996;50:317-320.

   408.     Schepis C, Siragusa M, Palazzo R, Batolo D, Romano C. Milia-like idiopathic calcinosis cutis: an unusual dermatosis associated with Down syndrome. Br J Dermatol. 1996;134:143-146.

   409.     Nijhawan A, Baselga E, Gonzalez-Ensenat MA, Vicente A, Southern JF, Camitta BM, et al. Vesiculopustular eruptions in Down syndrome neonates with myeloproliferative disorders. Arch Dermatol. 2001;137:760-763.

   410.     Newman JS, Fung MA. Elastosis perforans serpiginosa in a patient with trisomy 21. Dermatol Online J. 2006;12:5.

   411.     Wilms A, Dummer R. [Elastosis perforans serpiginosa in Down syndrome]. Hautarzt. 1997;48:923-925.

   412.     Vivier du A, Munro DD. Alopecia areata, autoimmunity, and Down's syndrome. Br Med J. 1975;1:191-192.

   413.     Jacobs S, Grussendorf-Conen EI. [Disseminated eruptive syringomas in Down syndrome]. Hautarzt. 2004;55:70-72.

   414.     Hoffmann R, Happle R. [Alopecia areata. 1: Clinical aspects, etiology, pathogenesis]. Hautarzt. 1999;50:W222-W231.

   415.     Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol. 2000;42:549-566.

   416.     Storm W. Celiac disease and alopecia areata in a child with Down's syndrome. J Intellect Disabil Res. 2000;44 ( Pt 5):621-623.

   417.     McCulloch AJ, Ince PG, Kendall-Taylor P. Autoimmune chronic active hepatitis in Down's syndrome. J Med Genet. 1982;19:232-234.

   418.     Tazi-Ahnini R, di Giovine FS, McDonagh AJ, Messenger AG, Amadou C, Cox A, et al. Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): evidence of association with alopecia areata in the Down syndrome region. Hum Genet. 2000;106:639-645.

   419.     Hoffmann R, Happle R. [Alopecia areata. Part 2: Therapy]. Hautarzt. 1999;50:W310-W315.

   420.     Happle R. Proposed guidelines for the management of alopecia areata. Ned Tijdschr Derm Venereol. 2000;10:353-355.

   421.     Schepis C, Barone C, Lazzaro Danzuso GC, Romano C. Alopecia areata in Down syndrome: a clinical evaluation. J Eur Acad Dermatol Venereol. 2005;19:769-770.

   422.     Kubeyinje EP. Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs. East Afr Med J. 1994;71:674-675.

   423.     Sethuraman G, Malhotra AK, Sharma VK. Alopecia universalis in Down syndrome: response to therapy. Indian J Dermatol Venereol Leprol. 2006;72:454-455.

   424.     Hatamochi A, Ueki H. Successful treatment of alopecia areata with dinitrochlorobenzene in a patient with Down's syndrome. J Dermatol. 1984;11:191-193.

   425.     Norton SA, Demidovich CW, III. Down syndrome, alopecia universalis, and trachyonychia. Pediatr Dermatol. 1993;10:187-188.

   426.     Finn OA, Grant PW, McCallum DI, Raffle EJ. A singular dermatosis of Mongols. Arch Dermatol. 1978;114:1493-1494.

   427.     Kavanagh GM, Leeming JP, Marshman GM, Reynolds NJ, Burton JL. Folliculitis in Down's syndrome. Br J Dermatol. 1993;129:696-699.

   428.     Massey GV, Zipursky A, Chang MN, Doyle JJ, Nasim S, Taub JW, et al. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. Blood. 2006;107:4606-4613.

   429.     Uhara H, Shiohara M, Baba A, Shiohara J, Saida T. Transient myeloproliferative disorder with vesiculopustular eruption: Early smear is useful for quick diagnosis. J Am Acad Dermatol. 2009;60:869-871.

   430.     Allen TD. The non-neurogenic neurogenic bladder. J Urol. 1977;117:232-238.

   431.     Down JL. Observations on an ethnic classification of idiots. 1866. Ment Retard. 1995;33:54-56.

   432.     Skotko BG, Levine SP. What the other children are thinking: brothers and sisters of persons with Down syndrome. Am J Med Genet C Semin Med Genet. 2006;142C:180-186.

   433.     Buckley S. Living with Down syndrome. Down Syndrome Issues and Information. 2000.

   434.     Cuskelly M, Hauser-Cram P, Riper van M. Families of children with Down Syndrome: what we know and what we need to know. Down Syndrome Res Pract. 2009;12:105-113.

   435.     Spiker D, Hopmann MR. The effectiveness of early intervention for children with Down Syndrome. In: Guralnick MJ, editor. The effectiveness of early intervention.Baltimore: Paul H Brookes Publishing Co.; 1997.

   436.     Pelchat D, Bisson J, Ricard N, Perreault M, Bouchard JM. Longitudinal effects of an early family intervention programme on the adaptation of parents of children with a disability. Int J Nurs Stud. 1999;36:465-477.

   437.     Pelchat D, Lefebvre H, Proulx M, Reidy M. Parental satisfaction with an early family intervention program. J Perinat Neonatal Nurs. 2004;18:128-144.

   438.     Pueschel SM. Towards optimal mental health of persons with Down syndrome. Downs Syndr Res Pract. 1998;5:43-46.

   439.     Rix J, Paige-Smith A. Approaches to supporting children's learning in childhood- the role of parents and professionals. Voordracht op 4th International Conference on developmental issues in Down Syndrome: early intervention and school education- from research to practice. 2005.

   440.     Guralnick MJ. Effectiveness of early intervention for vulnerable children: a developmental perspective. Am J Ment Retard. 1998;102:319-345.

   441.     Guralnick MJ. The system of early intervention for children with developmental disabilities. Handbook of mental retardation and developmental disabilities. 2006.

   442.     Nilholm C. Early intervention with children with Down syndrome- past and future issues. Down Syndrome Res Pract. 1996;4:51-58.

   443.     Fekkes M, Verrips GH, Hirasing RA. A nation-wide study into health-related quality of life (HRQOL) in children with Down syndrome. In: Graaf de EAB, Vermeer A, Heijmans HSA, Schuurman MIM, editors. Down Syndrome behind the Dykes: research in the Netherlands.Amsterdam: VU University Press; 1998. 67-74.

   444.     Gennep van ATG, Vermeer A, Meulen van der BF, Janssen CGC. Early intervention for young children with developmental disabilities: a longitudinal effect study. In: Graaf de EAB, Vermeer A, Heijmans HSA, Schuurman MIM, editors. Down Syndrome behind the Dykes: research in the Netherlands.Amsterdam: VU University Press; 1998. 123-132.